首页> 外国专利> Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities

Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities

机译:具有胸苷激酶和鸟苷酸激酶活性的胸苷激酶突变体和融合蛋白

摘要

The present invention provides isolated nucleic acid molecules encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations, at least one of the mutations encoding an amino acid substitution located toward the N-terminus from a DRH nucleoside binding site which increases a biological activity of the thymidine kinase, as compared to unmutated thymidine kinase. Such mutations include amino acid substitutions within a Q substrate binding domain which increases a biological activity of the thymidine kinase, as compared to unmutated thymidine kinase. Within a further aspect, fusion proteins are provided which have both guanylate kinase and thymidine kinase biological properties. Also provided are vectors suitable for expressing such DNA molecules, as well as methods for utilizing such vectors.
机译:本发明提供了分离的核酸分子,其编码包含一个或多个突变的疱疹病毒胸苷激酶,所述突变中的至少一个编码从DRH核苷结合位点向N-末端定位的氨基酸取代,所述突变增加了所述多肽的生物学活性。与未突变的胸苷激酶相比,胸苷激酶。这样的突变包括在Q底物结合域内的氨基酸取代,与未突变的胸苷激酶相比,其增加了胸苷激酶的生物学活性。在另一方面,提供了具有鸟苷酸激酶和胸苷激酶生物学特性的融合蛋白。还提供了适用于表达此类DNA分子的载体,以及利用此类载体的方法。

著录项

  • 公开/公告号US8236541B2

    专利类型

  • 公开/公告日2012-08-07

    原文格式PDF

  • 申请/专利权人 MARGARET E BLACK;

    申请/专利号US20100981428

  • 发明设计人 MARGARET E BLACK;

    申请日2010-12-29

  • 分类号C12N9;C12N9/12;C12N15;C07H21/04;

  • 国家 US

  • 入库时间 2022-08-21 17:27:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号